No significant differences were found between any of the three breast cancer subgroups (Fisher's Exact test, p > 0.10) when evaluated by any of other clinically relevant parameters (patient age,% tumor cells, tumor size, nodal status, grade, proliferation index, p53 status; Additional file 5). This evidence concerns the gene TP53 and breast cancer.